A global Japanese pharmaceutical company faced numerous challenges in analyzing the effectiveness of its HCP-targeted campaigns across the expansive EUCAN regions, including Italy, the UK, Canada, and Belgium.

We implemented a multi-pronged approach that covered the following aspects.
27% ↑
HCP engagement
75% ↓
Cost per conversion
220% ↑
Captured data sets